Intercept Pharmaceuticals reports data breach
Learn More
Intercept Pharmaceuticals, Inc., a biopharmaceutical company based in Morristown, New Jersey, reported a data breach discovered on February 22, 2024. Intercept Pharmaceuticals specializes in developing and commercializing therapeutics for rare and serious non-viral liver diseases, such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH).
The breach occurred under circumstances that are still being investigated, with limited information currently available on the exact cause.
The breach involved unauthorized access to confidential consumer information including:
- names,
- Social Security numbers,
- medical records,
- financial account information,
- driver’s license numbers.
No details are disclosed about the nature of the attack or the number of affected individuals.
The company has begun issuing notification letters to those whose information was compromised, advising them of the breach and suggesting steps to protect themselves from potential fraud and identity theft.
